GSTM1 and anemia (phenotype): Anemia patients were treated with oral iron and/or subcutaneous injection of erythropoiesis stimulating agents (ESAs), and the dosage was adjusted according to changes in Hb levels, with a maximum daily dose of ferrous succinate of 0.4 g and a maximum weekly dose of ESAs of 10,000 U.